Genotyping of clinical varicella-zoster virus isolates collected from Yunnan in Southwestern China
- Authors:
- Published online on: December 24, 2015 https://doi.org/10.3892/br.2015.562
- Pages: 209-214
Abstract
Introduction
Varicella-zoster virus (VZV) belongs to the α-herpesvirus family (1,2). VZV can infect humans and vertebrates (including chimpanzees and gorillas). The primary VZV infection in humans results in chickenpox. Following the recovery from chickenpox, the VZV becomes dormant in the sensory ganglia-like dorsal root ganglia (3,4). In certain conditions, VZV can reactivate and cause herpes zoster. There is a difference in onset time of primary VZV infection in different geographic regions (4). Generally, the infection time in people who have lived in temperate regions is earlier than those who have lived in tropical regions. In temperate regions, the first infection of VZV is mostly found in children, and in the tropical regions, the first infection is delayed until adulthood.
The genome of VZV is a linear duplex DNA molecule (5). The genome of VZV contained ~25,000 base pairs, including ≥70 open reading frames (ORFs). Genetic variations have been identified in the genome of VZV strains (6–13). Based on the specific single-nucleotide polymorphisms (SNPs) in ORFs 1, 21, 50 and 54, VZV strains have been divided into the following genotypes: A (Africa/Asia), B and C (Europe and North America), and J (Japanese) (6). By analyzing a short region of nucleotides [447 base pairs (bp)] in ORF 22, VZV strains could be divided into genotype E (Europe), genotype isolates J (Japanese) and genotype M (Mosaic) (13). The genotype M strains can be further divided into genotypes of M1, M2, M3 and M4 (13–15). The R5 variable regions (R5A and R5B) between ORF60 and ORF61 are also used to distinguish the genotypes of VZV strains (10,11). By phylogenetic analysis of the complete VZV genomes, the VZV strains could be broadly grouped into 5 clades (clades 1 and 3: European/North American strains; clade 2: Asian strains, particularly for the strains from Japan; clade 4: Certain strains from Europe; and clade 5: Indian strains) (16).
Until now, the VZV strains in China were not extensively studied. In the study by Loparev et al (13), 6 VZV samples in China were analyzed. The 3 samples in South China were all type M2. The other 3 samples in North China were all type E. Liu et al (17) collected 19 VZV samples from the patients with zoster or varicella in Hefei city of Anhui province, which is located in the middle Eastern part of China (18). The collected VZV isolates were grouped into genotype J or J1. The genotype of R5A and R5B were found in these isolates by analyzing the R5 variable region. In the present study, 42 VZV isolates were collected from Yunnan province of Southwestern China. Using the described genotyping method of Liu et al (17), a genetic characterization of the VZV strains was made in Southwestern China.
Materials and methods
Patients and clinical samples
The VZV isolates were collected from the 42 ambulatory and hospitalized patients with herpes zoster in The First People's Hospital of Yunnan Province (The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China) between August 2013 and December 2014. Vesicle fluid was collected from skin lesions, and the collected samples were stored at −20°C. The patients were all Han Chinese in the Yunnan province of Southwestern China. The study was approved by the Institutional Ethics Committee of the First People's Hospital of Yunnan Province. The written informed consent was signed and obtained from all the patients who participated. The study was performed according to the principles of the Declaration of Helsinki. Genomic DNA of VZV was extracted from vesicle fluid from skin lesions using a viral DNA extraction kit (Da An Gene Co., Ltd., of Sun Yat-Sen University, Guangzhou, China). The collected isolates were first detected by nested polymerase chain reaction (PCR) and quantitative PCR, as described by Weidmann et al (19). The results of the nested PCR and quantitative PCR showed that all the collected isolates exhibited the VZV gene.
PCR and sequencing
PCR was performed in a 25-µl reaction mixture containing 10X LA PCR Buffer II (Mg2+ Plus), 2.5 units of TaKaRa LA Taq (Takara Bio, Inc., Dalian, China), 50 µM of each deoxyribonucleotide, 0.2 µM of each primer and 50 ng DNA. The primers for amplifying and sequencing the fragments of the VZV genes referred to the previous studies by Liu et al (17), Barrett-Muir et al (6), Hawrami and Breuer (10) and Loparev et al (13), and are shown in Table I. The conditions for PCR amplification was as follows: A denaturation cycle at 94°C for 5 min, followed by 35 cycles at 94°C for 30 sec, annealing at 55°C for 30 sec and extension at 72°C for 40 sec, and ending with a final extension at 72°C for 7 min.
The PCR products of ORFs 1, 21, 22 and 54 in the VZV genes were purified using Genomic DNA Purification kits (Tiangen Biotech, Beijing, China) and were sequenced using the forward and reverse primers and the Big Dye Terminator version 3.1 Cycle Sequencing kit (Applied Biosystems, Carlsbad, CA, USA) on an ABI PRISM 3730 DNA sequencer (Applied Biosystems).
Restriction enzyme reactions
Restriction endonuclease digestion was performed in a 20 µl mixture containing 7 µl PCR products, 1 µl endonuclease (BglI, PstI or SmaI; Takara Bio Inc.), 2 µl of the accompanying 10X endonuclease buffer and 13 µl sterile water. The reaction mixture for BglI and PstI was incubated at 37°C for 3 h. The reaction mixture for SmaI was incubated at 30°C for 3 h. The digested products of BglI, PstI and SmaI were resolved by 6% polyacrylamide gels and were silver stained prior to visualization. The genotyping data were further validated by sequencing 2 randomly selected VZV samples.
Results
Restriction fragment length polymorphism (RFLP) analysis of ORF 38, 54 and 62
The specific SNPs in the VZV strains that are located in ORFs 38, 54 and 62 have been used as genetic markers in the study of VZV epidemiology. The PCR products of ORFs 38, 54 and 62 in the VZV genes were amplified and they were 647, 497 and 268 bp, respectively. RFLP analysis was used to determine the genotype of ORF38 (PstI), ORF54 (BglI) and ORF62 (SmaI) in the collected VZV isolates, as shown in Fig. 1. The PCR products of ORF38 were digested by PstI, and produced 2 fragments of 357 and 290 bp. The digestion of PCR products of ORF54 by BglI yielded 2 fragments of 256 and 241 bp. Similarly, the PCR products of ORF62 were digested by SmaI, and produced 3 fragments of 153, 79 and 36 bp. These data indicated that the VZV isolates collected in the study contained the cleaving site of PstI, BglI and SmaI, and that the collected isolates were all BglI positive (BglI+), PstI+ and SmaI+ (Table II).
Analysis of the R5 variable region
The R5 variable region has been shown to be vary among different VZV strains. The R5 variable region was amplified by PCR and analyzed by electrophoresis to determine its distribution in the collected VZV isolates. The representative results are shown in Fig. 1. The PCR products of R5A were 359 bp, while the PCR products of R5B were 471 bp. In the collected VZV isolates, R5A and R5B were observed. The percentages of R5A and R5B were 46.4 and 53.6%, respectively, in the collected isolates.
Nucleotide sequence analysis of ORFs 1, 21, 22 and 54
The sequence of ORFs 1, 21, 22 and 54 in VZV genes have been sequenced and analyzed in certain areas of the world, such as the United Kingdom, Brazil and Anhui city of China. Therefore, a nucleotide sequence analysis was performed on ORFs 1, 21, 22 and 54 in the collected VZV isolates. The informative polymorphic markers on the regions are shown in Fig. 2. Based on the genotyping scheme of Barret-Muir et al (6), the VZV isolates in the study could be grouped into genotype J1 (41/42) or A1 (1/42), as shown in Fig. 2A. The VZV isolates could be grouped into genotype J (41/42) or M2 (1/42) according to the genotyping scheme of Loparev et al (13), as shown in Fig. 2B.
Discussion
VZV is highly infectious for those with no VZV infection history, and becomes dormant in the sensory ganglia following the first infection. The genome of VZV is highly conserved compared to other pathological viruses, such as human papilloma virus. This may be due to the low reproduction of VZV in the infected hosts. This feature limits the frequency of the introduction of new mutations in VZV genes. As the advancement of VZV molecular epidemiology occurs, numerous genomic variations have been identified in VZV strains. Based on these genomic variations, the VZV strains have been classified into different genotypes. The VZV genotypes in China are rarely studied. The present study made a preliminary study on the genotypes of VZV isolates collected from Yunnan province of Southwestern China. To the best of our knowledge, this is the first investigation on VZV genotype in this region of China.
The genotype of VZV strains is associated with climate. In temperate regions, the VZV strains are often PstI+ and BglI negative (BglI−) in ORF38 and ORF54, while the majority of VZV strains in tropical regions are PstI+ and BglI+ (13,20–22). In the present study, the VZV isolates collected from the Yunnan province of Southwestern China were all PstI+ and BglI+ in ORF38 and ORF54 (Fig. 1A and Table II). The present results are consistent with the findings that the VZV strains in the tropical regions are often PstI+ and BglI− in ORF38 and ORF54, as the Yunnan province of China is located in the tropical regions.
ORF38 (PstI), ORF54 (BglI) and ORF62 (SmaI) in VZV genes are molecular genetic markers for the genotyping of VZV strains (18,20,21). The VZV isolates in the present study were all PstI+, BglI+ and SmaI+ (Fig. 1 and Table II). The VZV isolates collected from Anhui city of China and the strain MLS (6) were PstI+, BglI+ and SmaI− (wild-type VZV). The strain p-Oka was PstI−, BglI+ and SmaI− (17). The strain v-Oka was PstI−, BglI+ and SmaI+ (17). The results indicated that the VZV isolates collected from the Yunnan province of Southwestern China were different from that of Anhui city of middle eastern China. The results supported the conclusion that the genotype of VZV strains may vary in different regions of China. Further studies are required to find out the VZV distributions in China.
The R5 variable region in the VZV genes has been shown to be geographically related (10,23). The type of R5A (359 bp) is mainly found in Europe and North America. The type of R5B (471 bp) is a major type in Japan. In the present study, R5A and R5B were observed in the collected VZV isolates (Fig. 1). The genotype frequency of R5A and R5B are nearly identical in these samples. The results are consistent with the findings by Liu et al (17). It is possible that either R5A or R5B is equally distributed in Chinese VZV strains.
Until now, there was no gold standard VZV genotyping scheme, although several genotyping schemes have been proposed in recent years. The genetic variations were identified in VZV ORFs 1, 21, 22, 50 and 54 (17,19,24,25). By referring to the SNPs in VZV ORFs 1, 21, 50 and 54, the VZV strains could be grouped into 4 genotypes: A, B, C and J. By referring to the VZV ORF22, 7 VZV genotypes are identified, which were E1, E2, J, M1, M2, M3 and M4. The VZV strains of genotype J are most common in Asia, particular in Japan. In the present study, the above genotyping scheme was used to analyze the VZV samples collected from the Yunnan province of Southwestern China (Fig. 2). The collected VZV isolates are mainly genotype J or J1, which is a major genotype in Asia. The results are consistent with the finding by Liu et al (17), who collected the VZV isolates from Anhui city of middle eastern China, which were genotyped as J or J1. In addition to the previously reported genetic variations in the VZV genes, no new genetic variations were identified in the collected VZV isolates by sequencing the ORFs 1, 21, 22 and 54 in VZV genes. The results indicated that the VZV strains in Yunnan province may be highly conserved, as several reports have shown new genetic variations in these sequenced fragments. Of note, one sample in the collected isolates was classified as genotype A1 or M2. This may be due to the population migrations.
In conclusion, a preliminary study was performed on VZV genotypes in the Yunnan province of Southwestern China. The results of the present study will aid in the understanding of the genetics of VZV in China. The limitation of the study is that the sample size is small, although it is larger than the previous studies in China. Further studies with a larger sample size are required to understand the VZV genotype distributions in this region and China.
Acknowledgements
The present study was supported by the Education Commission of Yunnan Province (grant no. 2014Z036) and the Kunming University of Science and Technology (grant no. KKZ3201360025). The authors would like to thank Dr Ping Cao for collecting the VZV samples, and the patients who participated.
References
Nagel MA, Cohrs RJ, Mahalingam R, et al: The varicella zoster virus vasculopathies: Clinical, CSF, imaging and virologic features. Neurology. 70:853–860. 2008. View Article : Google Scholar : PubMed/NCBI | |
Elkind MS: The varicella zoster virus vasculopathies: Clinical, CSF, imaging, and virologic features. Neurology. 72:1028–1030; author reply 129–130. 2009. View Article : Google Scholar : PubMed/NCBI | |
Nagel MA and Gilden DH: The protean neurologic manifestations of varicella-zoster virus infection. Cleve Clin J Med. 74:489–494, 496, 498, 499 passim. 2007. View Article : Google Scholar : PubMed/NCBI | |
Becerra JC, Sieber R, Martinetti G, et al: Infection of the central nervous system caused by varicella zoster virus reactivation: A retrospective case series study. Int J Infect Dis. 17:e529–e534. 2013. View Article : Google Scholar : PubMed/NCBI | |
Peters GA, Tyler SD, Grose C, et al: A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J Virol. 80:9850–9860. 2006. View Article : Google Scholar : PubMed/NCBI | |
Barrett-Muir W, Scott FT, Aaby P, et al: Genetic variation of varicella-zoster virus: Evidence for geographical separation of strains. J Med Virol. 70(Suppl 1): S42–S47. 2003. View Article : Google Scholar : PubMed/NCBI | |
Carr MJ, McCormack GP and Crowley B: Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003. J Med Virol. 73:131–136. 2004. View Article : Google Scholar : PubMed/NCBI | |
Muir WB, Nichols R and Breuer J: Phylogenetic analysis of varicella-zoster virus: Evidence of intercontinental spread of genotypes and recombination. J Virol. 76:1971–1979. 2002. View Article : Google Scholar : PubMed/NCBI | |
Faga B, Maury W, Bruckner DA, et al: Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology. 280:1–6. 2001. View Article : Google Scholar : PubMed/NCBI | |
Hawrami K and Breuer J: Analysis of United Kingdom wild-type strains of varicella-zoster virus: Differentiation from the Oka vaccine strain. J Med Virol. 53:60–62. 1997. View Article : Google Scholar : PubMed/NCBI | |
Hawrami K, Harper D and Breuer J: Typing of varicella zoster virus by amplification of DNA polymorphisms. J Virol Methods. 57:169–174. 1996. View Article : Google Scholar : PubMed/NCBI | |
Loparev VN, Argaw T, Krause PR, et al: Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol. 38:3156–3160. 2000.PubMed/NCBI | |
Loparev VN, Gonzalez A, Deleon-Carnes M, et al: Global identification of three major genotypes of varicella-zoster virus: Longitudinal clustering and strategies for genotyping. J Virol. 78:8349–8358. 2004. View Article : Google Scholar : PubMed/NCBI | |
Norberg P, Liljeqvist JA, Bergstrom T, et al: Complete-genome phylogenetic approach to varicella-zoster virus evolution: Genetic divergence and evidence for recombination. J Virol. 80:9569–9576. 2006. View Article : Google Scholar : PubMed/NCBI | |
Sergeev N, Rubtcova E, Chizikov V, et al: New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray. J Virol Methods. 136:8–16. 2006. View Article : Google Scholar : PubMed/NCBI | |
Chow VT, Tipples GA and Grose C: Bioinformatics of varicella-zoster virus: Single nucleotide polymorphisms define clades and attenuated vaccine genotypes. Infect Genet Evol. 18:351–356. 2013. View Article : Google Scholar : PubMed/NCBI | |
Liu J, Wang M, Gan L, et al: Genotyping of clinical varicella-zoster virus isolates collected in China. J Clin Microbiol. 47:1418–1423. 2009. View Article : Google Scholar : PubMed/NCBI | |
Jiang L, Gan L, Chen J, et al: Genetic analysis of clinical VZV isolates collected in China reveals a more homologous profile. Biomed Res Int. 2013:6812342013. View Article : Google Scholar : PubMed/NCBI | |
Weidmann M, Meyer-König U and Hufert FT: Rapid detection of herpes simplex virus and varicella-zoster virus infections by real-time PCR. J Clin Microbiol. 41:1565–1568. 2003. View Article : Google Scholar : PubMed/NCBI | |
LaRussa P, Steinberg S, Arvin A, et al: Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J Infect Dis. 178(Suppl 1): S64–S66. 1998. View Article : Google Scholar : PubMed/NCBI | |
LaRussa P, Lungu O, Hardy I, et al: Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol. 66:1016–1020. 1992.PubMed/NCBI | |
Quinlivan M, Gershon AA, Steinberg SP, et al: An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus. J Med Virol. 75:174–180. 2005. View Article : Google Scholar : PubMed/NCBI | |
Sauerbrei A, Eichhorn U, Gawellek S, et al: Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain. J Med Virol. 71:313–319. 2003. View Article : Google Scholar : PubMed/NCBI | |
Quinlivan M, Hawrami K, Barrett-Muir W, et al: The molecular epidemiology of varicella-zoster virus: Evidence for geographic segregation. J Infect Dis. 186:888–894. 2002. View Article : Google Scholar : PubMed/NCBI | |
Bostikova V, Bostik P, Chlibek R, et al: Molecular epidemiology of varicella zoster virus. Epidemiol Mikrobiol Imunol. 59:21–24. 2010.PubMed/NCBI |